Clinical Trials Browser

Active not recruiting × Head and Neck Neoplasms × niraparib × Clear all

NCT04313504 2024-08-01

Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC

Phase 2 Active not recruiting

Head and Neck Neoplasms